RxDoctor Payments Data

Mary Suarez

Family · Tampa, FLNPI 1588393953

Payments from drug & device makers

$6,556in general payments, 2019–2025

Across 250 payments — averaging $26.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Myriad Genetic Laboratories, Inc.$897
  • Bayer$833
  • Dendreon Pharmaceuticals LLC$704
  • Progenics Pharmaceuticals, Inc.$487
  • Blue Earth Diagnostics$483
  • Sumitomo Pharma America, Inc.$439
  • plus $3K from 23 others

What the payments were for

  • Consulting fees$3756%
  • Food & beverage$6,18194%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,556 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
ErleadaApalutamide326$4,922,794
NubeqaDarolutamide207$2,748,762
XtandiEnzalutamide50$687,010
OrgovyxRelugolix244$664,483
XgevaDenosumab11$33,999
Abiraterone Acetate22$22,886
Tamsulosin Hcl287$4,033
Tadalafil14$1,632
Venlafaxine Hcl26$988
Alfuzosin Hcl ErAlfuzosin Hcl38$837
Methylprednisolone55$472
Ciprofloxacin Hcl38$312
Alendronate Sodium13$93

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonErleada$254$4,922,794326 claims
BayerNubeqa$833$2,748,762207 claims
Astellas Pharma US IncXtandi$195$687,01050 claims
Sumitomo Pharma America, Inc.Orgovyx$439$664,483244 claims
Janssen Scientific Affairs, LLCAbiraterone Acetate$375$22,88622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.

Other family in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →